Search

everythinglearnresearchcommunity

for

Search:↓

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

Some skin medications are safe during pregnancy and breastfeeding, but others can harm the baby and should be avoided.

Some skin lymphomas can look like common skin issues and need careful testing to diagnose correctly.

A woman with severe angioedema improved significantly after treatment with rituximab.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

Satoyoshi syndrome can occur without causing premature ovarian failure.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Timely diagnosis and aggressive treatment with high-dose steroids and B-cell depletion therapies are effective for severe acute cutaneous lupus.

Digital gangrene can be an initial symptom of late-onset systemic lupus erythematosus.

A woman with lymphoma had a rare skin rash on her scalp and forehead, which was hard to diagnose but responded well to treatment.

The VII International Congress of Dermocaribe in Colombia was a major dermatology event with over 50 lectures on various skin conditions and treatments.

Rituximab may cause skin issues, but baricitinib can help improve them.

Rituximab treatment led to complete hair regrowth and improved skin in a woman with pemphigus foliaceus.

Digital gangrene can be an unusual first sign of late-onset lupus.

Digital gangrene can be a rare first sign of late-onset systemic lupus erythematosus.

Digital gangrene can be an early sign of late-onset systemic lupus erythematosus.

Rituximab therapy successfully treated a patient's complete body hair loss and was effective for six years.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

Rituximab effectively treated a woman's bone lymphoma that was resistant to other treatments.

Rituximab leads to longer remission and fewer side effects than cyclophosphamide.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.

Ruxolitinib cream effectively treats skin conditions like atopic dermatitis and vitiligo with minimal side effects.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

Bendamustine combined with rituximab is an effective and well-tolerated treatment for certain types of lymphoma.

Ruxolitinib can cause a delayed skin reaction on the nose.

Bendamustine, often combined with other drugs, is effective and less toxic for certain blood cancers, but less effective for young, fit patients with CLL.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.